Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CHEK Check-Cap	$0.77 -0.6%	$0.81	$0.56 ▼ $3.04	$4.51M	0.22	377,436 shs	8,448 shs
HSCS HeartSciences	$3.84 -2.0%	$3.61	$2.36 ▼ $5.77	$4.24M	2.56	123,253 shs	116,283 shs
ICU SeaStar Medical	$0.42 -0.7%	$1.14	$0.31 ▼ $13.85	$4.74M	-0.89	1.48 million shs	6.79 million shs
NUWE Nuwellis	$0.26 +1.1%	$0.73	$0.21 ▼ $6.61	$1.12M	0.48	3.41 million shs	1.62 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CHEK Check-Cap	-0.65%	+1.46%	-10.00%	-3.16%	-62.68%
HSCS HeartSciences	-2.04%	+9.09%	-10.28%	+34.69%	-25.87%
ICU SeaStar Medical	-0.73%	-57.15%	-65.30%	-75.30%	-94.45%
NUWE Nuwellis	+1.14%	-7.49%	-71.03%	-73.54%	-94.85%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CHEK Check-Cap	1.2389 of 5 stars	0.0	5.0	3.3	0.0	0.6
HSCS HeartSciences	2.8261 of 5 stars	3.5	3.0	3.3	0.0	1.3
ICU SeaStar Medical	0.6893 of 5 stars	0.0	3.0	2.9	1.7	0.0
NUWE Nuwellis	3.3582 of 5 stars	3.5	5.0	3.3	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CHEK Check-Cap	0.00	N/A	N/A	N/A
HSCS HeartSciences	3.00	Buy	$13.00	238.54% Upside
ICU SeaStar Medical	0.00	N/A	N/A	N/A
NUWE Nuwellis	3.00	Buy	$17.00	6,489.15% Upside

Current Analyst Ratings Breakdown

Latest NUWE, CHEK, HSCS, and ICU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 6/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CHEK Check-Cap	N/A	N/A	N/A	N/A	$4.05 per share	N/A
HSCS HeartSciences	$20K	207.36	N/A	N/A	$11.16 per share	0.34
ICU SeaStar Medical	$140K	33.59	N/A	N/A	($0.34) per share	-1.24
NUWE Nuwellis	$8.74M	0.13	N/A	N/A	$1.49 per share	0.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CHEK Check-Cap	-$17.57M	-$3.00	N/A	∞	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	-$6.61M	-$7.48	N/A	N/A	N/A	N/A	-178.80%	-109.28%	8/4/2025 (Estimated)
ICU SeaStar Medical	-$24.83M	-$3.47	N/A	∞	N/A	N/A	N/A	-313.28%	8/12/2025 (Estimated)
NUWE Nuwellis	-$11.16M	-$18.24	N/A	N/A	N/A	-112.09%	-655.31%	-141.83%	8/12/2025 (Estimated)

Latest NUWE, CHEK, HSCS, and ICU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/14/2025	Q1 2025	ICU SeaStar Medical	-$0.52	-$0.44	+$0.08	-$0.44	$0.15 million	$0.29 million
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/27/2025	Q4 2024	ICU SeaStar Medical	-$0.89	-$0.90	-$0.01	-$0.90	$0.15 million	$0.07 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CHEK Check-Cap	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
ICU SeaStar Medical	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CHEK Check-Cap	N/A	N/A	N/A
HSCS HeartSciences	N/A	1.02	0.83
ICU SeaStar Medical	N/A	0.96	0.96
NUWE Nuwellis	N/A	2.23	1.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CHEK Check-Cap	1.07%
HSCS HeartSciences	17.24%
ICU SeaStar Medical	1.69%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
CHEK Check-Cap	0.48%
HSCS HeartSciences	1.80%
ICU SeaStar Medical	1.30%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CHEK Check-Cap	80	5.85 million	5.82 million	Not Optionable
HSCS HeartSciences	10	1.08 million	1.06 million	Not Optionable
ICU SeaStar Medical	2	11.20 million	11.06 million	Not Optionable
NUWE Nuwellis	70	4.37 million	4.30 million	Not Optionable

NUWE, CHEK, HSCS, and ICU Headlines

Recent News About These Companies

Nuwellis, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

June 11, 2025 | nasdaq.com

Nuwellis announces pricing of $4.3M underwritten public offering

June 11, 2025 | finance.yahoo.com

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

June 10, 2025 | globenewswire.com

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

June 9, 2025 | globenewswire.com

Nuwellis Inc.

June 5, 2025 | barrons.com

Earnings call transcript: Nuwellis Q1 2025 shows growth in revenue, stock stable

May 14, 2025 | investing.com

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2025 Earnings Call Transcript

May 14, 2025 | msn.com

Q1 2025 Nuwellis Inc Earnings Call

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. Partners with KDI Precision Manufacturing to Streamline Operations and Enhance Aquadex Product Manufacturing

May 13, 2025 | nasdaq.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | manilatimes.netM

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates

May 13, 2025 | zacks.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | globenewswire.com

Nuwellis, Inc.: Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 13, 2025 | finanznachrichten.de

Nuwellis Q1 Earnings Preview

May 13, 2025 | msn.com

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025 | globenewswire.com

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025 | globenewswire.com

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

April 24, 2025 | globenewswire.com

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

April 22, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, CHEK, HSCS, and ICU Company Descriptions

Check-Cap NASDAQ:CHEK

$0.76 -0.01 (-0.65%)

Closing price 06/26/2025 03:50 PM Eastern

Extended Trading

$0.76 0.00 (0.00%)

As of 04:18 AM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

HeartSciences NASDAQ:HSCS

$3.84 -0.08 (-2.04%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$3.86 +0.02 (+0.52%)

As of 04:03 AM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

SeaStar Medical NASDAQ:ICU

$0.42 0.00 (-0.73%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$0.40 -0.02 (-4.50%)

As of 04:56 AM Eastern

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

Nuwellis NASDAQ:NUWE

$0.26 +0.00 (+1.14%)

Closing price 06/26/2025 04:00 PM Eastern

Extended Trading

$0.25 0.00 (-1.55%)

As of 04:52 AM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time